Source Natural Foods Share Price Today | Stock Price & Source Natural Foods Share Screener
As of October 5, 2026, the live Source Natural Foods share price (BSE: SOURCENTRL) is ₹115.00, up 7.08% from the previous close, with shares trading between ₹102.00 and ₹120.00 in today's trading session, and a 52-week range of ₹102.40–₹154.70. Check SOURCENTRL 52-week chart for the annual price range and momentum. Use the Source Natural Foods stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Source Natural Foods opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹21 and net income of ₹1, with EBITDA of ₹2, an operating margin of 11.0% and a profit margin of 4.8%.
Source Natural Foods Share Price Chart
Track the current stock price of Source Natural Foods with an interactive chart. Analyse SOURCENTRL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Source Natural Foods stock quote in one place.
The quote of ₹115.00 sits between the 52-week low of ₹102.40 and the 52-week high of ₹154.70, and the latest session moved 7.08% from the previous close.
Source Natural Foods Company Profile - Fundamental Screener
Screen Source Natural Foods company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SOURCENTRL shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE679C01027.
Company Details
Classification
Identifiers and Leadership
Source Natural Foods Balance Sheet Screener
Screen SOURCENTRL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹41, up from ₹36 in 2025.
Latest statistics put total assets at ₹41 and shareholder funds at ₹26, with a leverage ratio of 0.32.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 41 | 36 | 25 | 22 | 19 | 17 | 13 | 11 | 11 | 12 |
| Current Assets | 32 | 27 | 19 | 15 | 14 | 11 | 9 | 6 | 7 | 8 |
| Fixed Assets | 4 | 4 | 6 | 7 | 5 | 4 | 3 | 4 | 4 | 4 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 26 | 22 | 20 | 18 | 16 | 13 | 10 | 9 | 8 | 7 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 19 | 16 | 13 | 11 | 9 | 7 | 3 | 2 | 1 | 1 |
Source Natural Foods Income Statement Screener - Profit & Revenue Analysis
Screen Source Natural Foods income statement and profit fundamentals. Analyze SOURCENTRL quarterly results. Source Natural Foods reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹21 and net profit was ₹1, equal to earnings per unit of ₹1.93, at an operating margin of 11%.
In that period expenses were ₹19, interest cost ₹0 and tax ₹1. The next period listed, 2026-Jun, shows revenue of ₹22 and net profit of ₹1.
| Item | 2026-Mar | 2026-Jun | 2025-Jun |
|---|---|---|---|
Revenue and Expenses | |||
| Revenue | 21 | 22 | 12 |
| Expenses | 19 | 20 | 11 |
Operating Costs and Margins | |||
| EBITDA | 2 | 1 | 1 |
| Operating Profit % | 11.00% | 5.00% | 9.00% |
| Depreciation | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 |
Profit and Earnings | |||
| Profit Before Tax | 2 | 1 | 1 |
| Tax | 1 | 0 | 0 |
| Net Profit | 1 | 1 | 1 |
| EPS | 1.93 | 1.06 | 0.98 |
Source Natural Foods Cash Flow Screener - Liquidity Fundamentals
Screen SOURCENTRL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹3, and net cash flow was an outflow of ₹5.
Over the same period, investing activities used ₹2 and financing activities provided ₹0.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | -3 | 0 | 3 | 3 | -1 | 5 | 0 | 3 | 0 | -1 |
| Investing Activities | -2 | -5 | 0 | 0 | 0 | -2 | -1 | 0 | 0 | -2 |
Financing and Net Cash | ||||||||||
| Financing Activities | 0 | 5 | 1 | -1 | -1 | 0 | 0 | -2 | 0 | 2 |
| Net Cash Flow | -5 | 0 | 4 | 2 | -2 | 3 | -1 | 1 | 0 | -1 |
Source Natural Foods Shareholding Pattern Screener
See Source Natural Foods shareholding pattern with promoter, FII, and DII holdings. Check Source Natural Foods promoter holding and ownership changes for SOURCENTRL on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 74.37%, foreign institutions 0.00%, domestic institutions 0.00% and the public 18.70%, spread across 3,638 shareholders.
The shareholder count was 3,638 in 2026-Mar, compared with 3,628 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 18.70% | 19.61% | 19.98% | 18.96% | 18.79% | 18.68% | 21.38% | 22.54% |
| Other Holding | 6.94% | 6.03% | 5.65% | 6.67% | 6.84% | 6.95% | 4.25% | 3.09% |
| Shareholder Count | 3,638 | 3,628 | 3,849 | 3,752 | 3,778 | 3,705 | 3,387 | 3,966 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Source Natural Foods. Source Natural Foods dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹1.00 | 1.38% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Source Natural Foods Stock Index Membership - Nifty & Sensex
See which indices include Source Natural Foods stock. Check SOURCENTRL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Source Natural Foods Market Events Screener - Corporate Actions
Get Source Natural Foods corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Source Natural Foods stock events that may affect SOURCENTRL share price, along with derivatives, futures and options activity and sector gainers.
11 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.
It is followed by Quarterly Result Announcement dated August 10, 2026 and Quarterly Result Announcement dated May 28, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | 0.65% |
| 2026-08-10 | 2026-08-10 | Quarterly Result Announcement | NA | 1.05% |
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | 3.32% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | -3.73% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -2.54% |
| 2025-09-25 | 2025-09-25 | Annual General Meeting | NA | -0.15% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -2.93% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 3.56% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -6.79% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 6.09% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -7.93% |
Source Natural Foods Competitors Screener - Peer Stocks Comparison
Screen SOURCENTRL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 427,010 | 35.84 | 61,674 | 12.69% | 11,565 | 33.78 |
| Divis Laboratories | 244,125 | 84.36 | 11,067 | 13.95% | 2,568 | 49.73 |
| Torrent Pharmaceuticals | 181,512 | 84.01 | 13,886 | 20.34% | 2,138 | 41.48 |
| Zydus Life Science | 113,616 | 24.88 | 27,658 | 17.64% | 5,026 | 46.18 |
| Cipla | 107,890 | 32.42 | 29,045 | 2.24% | 3,870 | 32.87 |
| Laurus Labs | 106,517 | 98.56 | 6,868 | 22.01% | 890 | 56.11 |
| Mankind Pharma | 102,394 | 50.48 | 14,636 | 14.85% | 1,938 | 55.53 |
| Dr Reddys Laboratories | 100,412 | 31.47 | 35,059 | 3.90% | 4,158 | 52.91 |
| Aurobindo Pharma | 96,370 | 25.97 | 34,145 | 5.56% | 3,503 | 49.89 |
| Lupin | 91,961 | 16.71 | 29,039 | 26.75% | 5,356 | 29.12 |
Source Natural Foods Company Announcements - News & Reports Screener
Screen SOURCENTRL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 4, 2026.
The next most recent announcements are dated October 4, 2026 and October 3, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-04 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | - |
| 2026-10-04 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-10-03 | Closure of Trading Window | - |
| 2026-10-03 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-23 | Announcement Under Regulation 30 (LODR) Regulations 2015 - Receipt Of Ayush Quality Mark Certification | - |
| 2026-09-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-08 | Corporate Action-Board to consider Dividend | - |
| 2026-09-08 | Notice Of 31St Annual General Meeting | - |
| 2026-09-08 | Reg. 34 (1) Annual Report. | - |
| 2026-09-03 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | - |
| 2026-09-03 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-09-03 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-08-31 | Incorporation Of A Wholly Owned Subsidiary Company | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-12 | Proposed Incorporation Of Wholly Owned Subsidiary | - |
| 2026-08-10 | Financial Results For The Quarter Ended 30Th June 2026 | - |
| 2026-08-10 | Board Meeting Outcome for Outcome Of Board Meeting For The Quarter Ended June 30 2026 | - |
| 2026-08-05 | Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter Ended June 30 2026 | - |
| 2026-07-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-30 | Closure of Trading Window | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹115.00, within a 52-week range of ₹102.40 to ₹154.70. The P/E ratio is 20.34 and the P/B ratio is 9.13, with earnings per unit of ₹5.28. Market capitalisation stands at ₹73.99 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 7, 2026. This page covers 10 balance sheet periods, 3 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.